HZNP News 14.49 04/25/2014 05:42:17 Horizon Pharma Inc (HZNP

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Horizon Pharma Inc (HZNP) 14.49 $HZNP

Horizon Pharma awards inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4)
M2 - Thu Apr 24, 5:03AM CDT
Pharmaceutical company Horizon Pharma (NASDAQ:HZNP) on Wednesday granted stock options to ten new non-executive employees to purchase up to 76,500 shares of its common stock.

Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Wed Apr 23, 3:35PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on April 23, 2014 the Compensation Committee of its Board of Directors granted inducement awards to 10 new employees.

Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
PR Newswire - Wed Apr 23, 10:34AM CDT
On Tuesday, April 22, 2014, the NASDAQ Composite ended at 4,161.46, up 0.97%, the Dow Jones Industrial Average finished the session 0.40% higher at 16,514.37, and the S&P 500 closed at 1,879.55, up 0.41%. The gains were broad based as eight out of ten sectors finished on a higher note. A number of stocks saw large movements, including Centene Corp. (NYSE: CNC), Prana Biotechnology Ltd (NASDAQ: PRAN), Horizon Pharma Inc. (NASDAQ: HZNP) and Scientific Games Corp. (NASDAQ: SGMS). Free technical research on CNC, PRAN, HZNP and SGMS can be downloaded upon signing up at:

Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 7:41AM CDT
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)?

Horizon Pharma elects H Thomas Watkins to board
M2 - Fri Apr 18, 6:53AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) revealed on Thursday the addition of H Thomas Watkins to its board of directors.

Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors
Marketwire - Thu Apr 17, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors.

Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd.
Marketwire - Wed Apr 16, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that it has received notice of the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, in connection with its proposed acquisition of Vidara Therapeutics International Ltd. ("Vidara" . The waiting period was scheduled to expire on May 1, 2014. Completion of the transaction remains subject to approval by Horizon's stockholders and other customary closing conditions.

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Horizon Pharma announces Notice of Allowance for US Patent Application for RAYOS for treating a broad range of diseases
M2 - Fri Apr 11, 4:56AM CDT
Specialist pharmaceutical company Horizon Pharma (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers its US approved product RAYOS.

Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:33AM CDT
Horizon Pharma looks well positioned for a solid gain, but has been overlooked by investors lately. This Generic Drugs stock has actually seen estimates rise over the past month for the current fiscal year. This year’s expected earnings growth over the prior year is 147.1%, which should ultimately translate into price appreciation.

Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
Marketwire - Thu Apr 10, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS(R).

Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 03, 12:47PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma
PR Newswire - Wed Apr 02, 8:59AM CDT
On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:

Biotechs Giving Uncle Sam the Shaft
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 5:08PM CDT
As they say in real estate: location, location, location. Biotechs have been acquiring companies in large part for their address. Specifically, they're buying so they can move to places like Ireland, where taxes are substantially lower than in the...

Horizon Pharma grants inducement stock options to 26 new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Fri Mar 28, 4:55AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) said on Thursday that it has awarded inducement stock options to purchase an aggregate of 96,750 shares of its common stock to 26 new employees.

Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:47AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on HZNP’s earnings for the coming quarter and year.

Acquisitions, Appointments, and New Product Developments - Analyst Notes on Boston Scientific, Horizon Pharma, Alkermes, Agilent, and BD
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Boston Scientific Corporation (NYSE: BSX), Horizon Pharma Inc. (NASDAQ: HZNP), Alkermes Plc (NASDAQ: ALKS), Agilent Technologies Inc. (NYSE: A), and Becton, Dickinson and Co. (NYSE: BDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews

Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 0

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
CSMI Boosts CT's Cybersecurity for Defense Sector

Updated Category News Views 132

Paving the Way for Cybersecurity Excellence Out in chilly Connecticut, CSMI made a mark. The State's Office of Manufacturing picked them to join the advisory council for the Defense CyberSecure Program (CT-DCP). It ain’t just a pat on the back; it's a big deal for the region's defense and aerospace manufacturing gang. Connecticut's got its eyes set on beefing up its...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 244

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 0

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 53

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 66

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 84

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 88

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 0

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

Uwill Achieves Remarkable Growth as Third Fastest-Growing Firm

Updated Category News Views 278

Uwill Makes Its Mark in the Mental Health Arena In a remarkable achievement, Uwill has been recognized as one of the top mental health and wellness solutions for students, claiming the third position on the highly acclaimed Inc. Regionals: Northeast list. This ranking highlights the company's commitment to innovation and growth, as it operates in a vital field that...

Continue Reading
South University Celebrates Milestone With Ceremony and Capsule

Updated Category News Views 110

South University Marks 125 Years of Educational Excellence South University is proud to announce a significant celebration to commemorate its 125th anniversary. The event, which will include a time capsule ceremony along with a reception, is set to take place at the university's historic Savannah campus. This occasion not only honors the past but also emphasizes the...

Continue Reading
Insights on Ultra Clean Holdings' Upcoming Class Action Lawsuit

Updated Category News Views 160

Understanding the Class Action Lawsuit Against Ultra Clean Holdings The Gross Law Firm is here to inform investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) about an important class action lawsuit that is currently pending. This notice is directed towards shareholders who acquired shares of UCTT during the specified class period. The opportunity to participate in this...

Continue Reading
APA.LIVE and YES, And… Forge a Fresh Event Path

Updated Category News Views 30

Innovation Takes Center Stage in Live Productions Well, this one's a bit different, folks. When it comes to corporate meetings that are supposed to shake off the dust of dread and monotony, APA.LIVE is punching above its weight class. These guys are taking a swing at traditional snooze-inducing conferences by partnering with YES, And… Creative Services. With APA.LIVE...

Continue Reading
NVIDIA's Blackwell Demand Skyrockets Amid Strategic Partnership

Updated Category News Views 207

NVIDIA Corporation (NASDAQ: NVDA) was making waves back in 2024, boasting a year-to-date surge of 136% as traders flocked to the innovative tech company. Shares popped by 1.6% following CEO Jensen Huang’s bullish remarks on CNBC's Closing Bell Overtime regarding their latest product, Blackwell. You could practically hear the buzz on the trading floor as desks reacted to...

Continue Reading